Application of dose response model for infection on selected case of oral mouth wash product

Microbial contamination of pharmaceutical products constitutes a great concern for stakeholders and professionals in the field. Special attention is brought to multidose medicinal products with considerable water activities (aw). Such pharmaceutical products are prone to microbial spoilage with seri...

Full description

Bibliographic Details
Main Author: Mostafa Eissa
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2016-09-01
Series:Trends in Pharmaceutical Sciences
Online Access:https://tips.sums.ac.ir/article_42199_b059d5e3d89c5cf67f175528242ecaf6.pdf
id doaj-29b16c8692db4ecc867161915934dc21
record_format Article
spelling doaj-29b16c8692db4ecc867161915934dc212021-07-14T06:18:55ZengShiraz University of Medical SciencesTrends in Pharmaceutical Sciences2423-56522016-09-012317718042199Application of dose response model for infection on selected case of oral mouth wash productMostafa EissaMicrobial contamination of pharmaceutical products constitutes a great concern for stakeholders and professionals in the field. Special attention is brought to multidose medicinal products with considerable water activities (aw). Such pharmaceutical products are prone to microbial spoilage with serious consequences on patients’ health and even their lives. The current investigation aimed to study new approach in the risk assessment of the contamination of oral antiseptic mouthwash in a quantitative manner using dose-response model of microbial infection. The present study combines both preservative efficacy test (PET) results with specific dose-response model of indicator bacteria. The risk was assessed at its maximum level using the worst case scenario of repeated contamination of the medicine bottle with each use. The indicator microbe selected was Escherichia coli with two models: exponential and beta Poisson based on antimicrobial efficacy test (AET) results. The mouthwash met the acceptance criteria of USP<51> PET, with notably strong effect on bacteria and yeast (not recovered from culture media) at any testing points (14 and 28 days). On the other hand, Aspergillus brasiliensis showed significant reduction after 28 days only. The current investigation showed that repeated product contamination with each use increased the risk of infection and different contaminating varies of the same microbial species constituted various hazard levels, although the antimicrobial properties of the product were sufficiently strong against the dedicated microbe (>3.00 log reduction (LR)). The current study provided new insight for the conventional pharmacopeial AET and demonstrated the limitation of it.https://tips.sums.ac.ir/article_42199_b059d5e3d89c5cf67f175528242ecaf6.pdf
collection DOAJ
language English
format Article
sources DOAJ
author Mostafa Eissa
spellingShingle Mostafa Eissa
Application of dose response model for infection on selected case of oral mouth wash product
Trends in Pharmaceutical Sciences
author_facet Mostafa Eissa
author_sort Mostafa Eissa
title Application of dose response model for infection on selected case of oral mouth wash product
title_short Application of dose response model for infection on selected case of oral mouth wash product
title_full Application of dose response model for infection on selected case of oral mouth wash product
title_fullStr Application of dose response model for infection on selected case of oral mouth wash product
title_full_unstemmed Application of dose response model for infection on selected case of oral mouth wash product
title_sort application of dose response model for infection on selected case of oral mouth wash product
publisher Shiraz University of Medical Sciences
series Trends in Pharmaceutical Sciences
issn 2423-5652
publishDate 2016-09-01
description Microbial contamination of pharmaceutical products constitutes a great concern for stakeholders and professionals in the field. Special attention is brought to multidose medicinal products with considerable water activities (aw). Such pharmaceutical products are prone to microbial spoilage with serious consequences on patients’ health and even their lives. The current investigation aimed to study new approach in the risk assessment of the contamination of oral antiseptic mouthwash in a quantitative manner using dose-response model of microbial infection. The present study combines both preservative efficacy test (PET) results with specific dose-response model of indicator bacteria. The risk was assessed at its maximum level using the worst case scenario of repeated contamination of the medicine bottle with each use. The indicator microbe selected was Escherichia coli with two models: exponential and beta Poisson based on antimicrobial efficacy test (AET) results. The mouthwash met the acceptance criteria of USP<51> PET, with notably strong effect on bacteria and yeast (not recovered from culture media) at any testing points (14 and 28 days). On the other hand, Aspergillus brasiliensis showed significant reduction after 28 days only. The current investigation showed that repeated product contamination with each use increased the risk of infection and different contaminating varies of the same microbial species constituted various hazard levels, although the antimicrobial properties of the product were sufficiently strong against the dedicated microbe (>3.00 log reduction (LR)). The current study provided new insight for the conventional pharmacopeial AET and demonstrated the limitation of it.
url https://tips.sums.ac.ir/article_42199_b059d5e3d89c5cf67f175528242ecaf6.pdf
work_keys_str_mv AT mostafaeissa applicationofdoseresponsemodelforinfectiononselectedcaseoforalmouthwashproduct
_version_ 1721304020132298752